View Rule

This rule would propose changes to strengthen and improve the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicare cost plan, and Programs of All-Inclusive Care for the Elderly (PACE). This rule would also codify Part D provisions of the Inflation Reduction Act of 2022 (IRA). Proposals included in this rule are based on feedback and public consultations with Medicare Advantage Organizations (MAOs), Part D sponsors, health care provider organizations, pharmaceutical manufacturers, pharmacy organizations, and beneficiary advocates, including regular listening sessions and other engagements to assist in the implementation of IRA provisions, gain input, identify areas that can be improved, and address vulnerabilities in the Part C and D programs.